Zobrazeno 1 - 10
of 90
pro vyhledávání: '"W, Splinter"'
Publikováno v:
Scandinavian Journal of Haematology. 20:29-36
A case report is presented of a 77-year-old woman suffering from a composite lymphoma, known as Richter's Syndrome, consisting of chronic lymphocytic leukaemia (CLL) and diffuse histiocytic lymphoma. Light-microscopic investigation revealed the prese
Autor:
T. Lopez, Jerrold Lerman, A. J. T. Kirkham, I A Spahr-Schopfer, W. Splinter, Cedric Prys-Roberts, I. Murat, C. Lejus, T. Taivainen
Publikováno v:
Anaesthesia. 55:870-876
We compared the efficacy and safety of a remifentanil (0.25 µg.kg−1.min−1)-based balanced anaesthetic technique with a bupivacaine-based regional anaesthetic technique in an open label, multicentre study in 271 ASA physical status 1 or 2 childre
Autor:
Tarek Sahmoud, J. Burghouts, Desmond Curran, G. Giaccone, F. Gozzelino, Anne Kirkpatrick, Pe Postmus, Giorgio V. Scagliotti, Harry J.M. Groen, T. A. W. Splinter
Publikováno v:
Scopus-Elsevier
European Journal of Cancer, 32A(9), 1498-1503. ELSEVIER SCI LTD
European Journal of Cancer, 32A(9), 1498-1503. ELSEVIER SCI LTD
Alternating chemotherapy for small cell lung cancer has been tested in several studies. Some have shown positive results that have not been confirmed in other studies. In all of the studies, however, the degree of non-cross-resistance in the regimens
Autor:
J. Genolla, S. A. Gomm, M. Szturmowicz, K. Østerlind, J. R. Hernandez, L. G. M. Jørgensen, T. A. W. Splinter, J. Løber, Peter Johnson
Publikováno v:
British Journal of Cancer
The influence of pretreatment serum neuron-specific enolase (S-NSE) in addition to more conventional prognostic factors on survival duration in small-cell lung cancer (SCLC) was investigated in 770 patients from nine centres in six countries. The oth
Autor:
T. Conroy, P. Cappelaere, M. Fabbro, A. A. Fauser, T. A. W. Splinter, M. Spielmann, M. Schneider, B. Chevallier, A. Goupil, J. Chauvergne, P. Fargeot, G. Prévot, P. OʼGrady, D. Green, J. Hardenberg, M. Boyce
Publikováno v:
American Journal of Clinical Oncology. 17:97-102
Dolasetron mesylate (MDL 73,147EF), a new serotonin receptor (5-HT3) antagonist was administered to 164 cancer patients naive or non-naive to chemotherapy, in single, rising doses of 10, 20, 30, 40, or 50 mg i.v. 15 minutes prior to an infusion of ci
Publikováno v:
Medical education. 45(10)
Medical students often fail to finish medical school within the designated time. An academic dismissal (AD) policy aims to enforce satisfactory progress and to enable early identification and timely support or referral of struggling students. In this
Publikováno v:
Medical education. 45(10)
A recent controlled study by our group showed that the dropout rate in the first 2 years of study of medical students selected for entry by the assessment of a combination of non-cognitive and cognitive abilities was 2.6 times lower than that of a co
Autor:
Maryska L.G. Janssen-Heijnen, Paul J. J. M. Klinkhamer, Ted A. W. Splinter, Rob M. Schipper, Wolter J. Mooi, Jan Willem Coebergh
Publikováno v:
Epidemiology, 12(2), 256-258. Lippincott Williams & Wilkins
We studied possible explanations for the deteriorating survival for adenocarcinoma of the lung between 1975 and 1994 in relation with trends in incidence. The proportion of adenocarcinoma among men has been increasing since 1975 and for those born af
Autor:
T. A. W. Splinter, A. Van De Gaast, C. F. Verkoelen, F. Boomsma, M. Vlastuin, G. Rijksen, T. C. Kok, K. G. Haglid
Publikováno v:
British Journal of Cancer
Neuron specific enolase (NSE) is widely used as a neuro-endocrine marker. However the presence of NSE in many non-neuroendocrine tissues has raised questions on the specificity of NSE. We have investigated NSE immunoreactivity (NSA-ag), gamma-enolase
Autor:
Ted A W, Splinter
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 153(14)